CN Stock MarketDetailed Quotes

002390 Guizhou Xinbang Pharmaceutical

Watchlist

3.92
+0.07+1.82%

Market Closed Apr 29 15:00 CST

7.62BMarket Cap25.96P/E (TTM)

Guizhou Xinbang Pharmaceutical Stock Forum

Moomoo AI

Mar 26 13:45

Three years ago, the market may have overestimated Guizhou Xinbang Pharmaceutical's EPS growth. The disconnect between its business metrics and share price could suggest overrating or a current opportunity. Last year's performance hints at unresolved challenges.

Earnings Growth of 1.1% Over 3 Years Hasn't Been Enough to Translate Into Positive Returns for Guizhou Xinbang Pharmaceutical (SZSE:002390) Shareholders

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall